-

02:51:16 PM

EHVVF Stock News

EHVVF - Ehave Inc

08/04/21 8:30 AM

OTC : EHVVF

Ehave Partners with Globally Recognized University to Target Hallucinogen Persisting Perception Disorder (HPPD)

Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, today announced a

RHEA-AI

neutral

07/29/21 8:30 AM

OTC : EHVVF

Hallucinogen Persisting Perception Disorder (HPPD) Research Initiated By Ehave

HPPD is a psychiatric disorder characterized by the persisting presence of sensory disturbances, most commonly visual, that resemble those produced by the use of hallucinogenic substances. Ehave believes psychedelics are extremely safe, especially under medical supervision, but believes

RHEA-AI

negative

07/13/21 8:30 AM

OTC : EHVVF

partnership

Ehave Releases Additional Information On Partnership With Cutting Edge Data Provider As It Expands Capabilities

Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic

RHEA-AI

positive

07/09/21 9:30 AM

OTC : EHVVF

partnershipmanagementclinical trial

Ehave Hires Institutional Review Board (IRB) As It Solidifies Partnership With Tristar Wellness Launching Ketamine Clinical Trials In Miami

Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced

RHEA-AI

neutral

07/06/21 8:30 AM

OTC : EHVVF

management

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Ehave, Inc., (OTC Pink: EHVVF) (the

RHEA-AI

positive

07/02/21 8:30 AM

OTC : EHVVF

Ehave, Inc. To Be One Of Four Main Sponsors At The Third Annual Psytech Summit on July 19th and 20th, 2021

Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and

RHEA-AI

neutral

07/01/21 8:30 AM

OTC : EHVVF

management

Ehave, Inc. Adds Published Child, Adolescent And Adult Psychiatrist To Its Medical Advisory Board

Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, continues its

RHEA-AI

very positive

06/29/21 8:30 AM

OTC : EHVVF

Health Wizz Co-Founder, Dr. Nitin Desai, To Assist And Advise Ehave On Mental Health Analytical Platforms

Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced

RHEA-AI

neutral

06/15/21 9:31 AM

OTC : EHVVF

Dr. Jeffrey Kamlet Internationally Recognized Expert on Cardiac Safety in Ibogaine Treatment Joins Ehave as Chief Medical Officer

Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the appointment of

RHEA-AI

neutral

06/03/21 9:47 AM

OTC : EHVVF

Ehave To Release Vaccine Passport As Part Of Its Medical Passport

Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering

RHEA-AI

neutral

Prev 1 2 3 Next